GHIT Request for Proposals: Product Development Platform 2025
The Global Health Innovative Technology Fund (GHIT Fund) announces the Request for Proposals (RFP) for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases.
Proposal details:
The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:
- Lead optimization.
- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation).
- Clinical Development (Phase 1, 2, and 3 studies, manufacturing scale-up).
- Parallel or concurrent development of multiple interventions (e.g., development of new drugs alongside improved diagnostic tools for disease control, advancing multiple promising drug candidates concurrently).
- Activities to support licensure and WHO pre-qualification.
Eligibility:
- There should be at least one eligible Japanese and one eligible non-Japanese organization as partners.
- Partnerships can be existing or new between Japanese and non-Japanese organizations.
- Each partner should have a history of health intervention R&D and have the expertise to know which projects represent potentially substantial additions to the field.
- Projects must address a priority need for the prevention or treatment of infectious diseases in developing countries.
Read more here.
Intent to Apply deadline, 28th of November, 2024 no later than 10:00 am JST.
